Key facts
- It has raised $1.2M; the latest was Angel (individual) ($1.2M) in Apr 2026.
- Notable investors include Incubateur Belle de Mai, La French Tech Aix-Marseille Région Sud.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Hairdex
- ·The full record, as it builds
Funding rounds
No funding rounds for Hairdex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hairdex
Provider of personalized hair restoration and medical coordination services intended for individuals experiencing hair loss and alopecia. The company's platform facilitates teleconsultations with specialized doctors, coordinates the delivery of custom-formulated prescriptions prepared by partner pharmacies, and implements a monitoring protocol including AI-driven trichoscopy to track hair density and thickness over time, enabling patients to access individualized medical care and clinical-grade pharmaceutical treatments tailored to their specific biological needs for long-term stabilization and growth.
- Sector
- Healthcare
- HQ
- Marseille, France
- Founded
- 2024
- Website
- hairdex.fr/
- Ownership
- Privately Held (backing)
Hairdex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hairdex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hairdex in its N-PORT filings yet. We sweep new filings monthly.